Immune Regulation News 11.31 August 23, 2019 | |
![]() | |
| |
TOP STORYMechanosensation of Cyclical Force by PIEZO1 Is Essential for Innate Immunity Researchers showed that cyclical hydrostatic pressure, similar to that experienced by immune cells in the lung, initiated an inflammatory response via the mechanically activated ion channel PIEZO1. [Nature] Abstract | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)Dietary Intake Regulates the Circulating Inflammatory Monocyte Pool Scientists showed that short-term fasting reduced monocyte metabolic and inflammatory activity and drastically reduced the number of circulating monocytes. [Cell] Full Article | Graphical Abstract Using IL-17A tracking-fate mouse models, the authors found that a significant fraction of lung CD4 tissue resident memory T (TRM) cells derived from IL-17A-producing effector (TH17) cells following immunization with heat-killed Klebsiella pneumoniae. [Cell] Abstract | Graphical Abstract Molecular Mechanisms of Lineage Decisions in Metabolite-Specific T Cells In addition to the known mucosal-associated invariant T cell (MAIT)1 and MAIT17 effector subsets selected on bone-marrow-derived hematopoietic cells, investigators identified 5-(2-oxopropylideneamino)-6-D-ribitylaminouracil-specific thymocytes that were selected on thymic epithelial cells and differentiated into CD44− naive T cells. [Nat Immunol] Abstract Scientists developed a blocking monoclonal antibody to human IL-1R3 and demonstrated that this antibody specifically inhibited signaling via IL-1, IL-33 and IL-36 in vitro. [Nat Immunol] Abstract Bhlhe40 and Bhlhe41 Transcription Factors Regulate Alveolar Macrophage Self‐Renewal and Identity Investigators identified the transcription factors Bhlhe40 and Bhlhe41 as novel regulators of alveolar macrophages—a population that provides the first line of immune defense and executes homeostatic functions in lung alveoli. [EMBO J] Abstract | Graphical Abstract Researchers found that Pten-null prostate tumors were strongly infiltrated by tumor-associated macrophages expressing C-X-C chemokine receptor type 2 (CXCR2), and activation of this receptor through CXCL2 polarized macrophages toward an anti-inflammatory phenotype. [Cell Rep] Full Article | Graphical Abstract The authors unexpectedly found high expression and activation of Bruton’s tyrosine kinase (BTK) in T cells. Deficiencies in BTK resulted in the impaired activation and proliferation of autoreactive T cells and ameliorated bone marrow failure in aplastic anemia. [Cell Mol Immunol] Full Article miR-146a directly inhibited type II innate lymphoid cell (ILC2) function and suppressed ILC2 proliferation both in vivo and in vitro. During stimulation of ILC2, miR-146a expression gradually increased with a decrease of cell proliferation. [Genes Immun] Abstract RRAGC mutations, targeted to the endogenous locus in mice, conferred a partial insensitivity to nutrient deprivation, but strongly exacerbated B cell responses and accelerated lymphomagenesis, while creating a selective vulnerability to pharmacological inhibition of mTORC1. [Nat Metab] Abstract Subscribe to our sister publications: Human Immunology News & Immunology of Infectious Disease News. | |
| |
REVIEWSZebrafish in Inflammasome Research Scientists discuss inflammasome research in zebrafish in light of current knowledge about mammalian inflammasomes. They summarize the evolutionary conservation of inflammasome components between zebrafish and mammals, highlighting the similarities and possible divergence in functions of these components. [Cells] Full Article Visit our reviews page to see a complete list of reviews in the immune regulation research field. | |
| |
INDUSTRY NEWSNGen Funding to Transform Manufacturing of Critical Materials in Gene Therapies NGen has approved Supercluster funding for a transformative $4.2 million project led by iVexSol Canada to develop an advanced manufacturing process for lentiviral vectors. [STEMCELL Technologies Inc.] Press Release Exagen and the University of Washington Collaborate on Lupus and Rheumatoid Arthritis Research Exagen Inc. announced a research collaboration with the University of Washington’s School of Medicine and Dr. Christian Lood, assistant professor of medicine, Division of Rheumatology. [Exagen Inc.] Press Release Kalytera to Conclude Phase II Clinical Study and Initiate Phase III Study Kalytera Therapeutics, Inc. announced that interim results from the company’s Phase II clinical study evaluating cannabidiol for the prevention of acute graft versus host disease are significantly positive, and, as a result, the company will not enroll the high dose cohort in its ongoing Phase II study, but will instead proceed directly to initiate a Phase III clinical registration study. [Kalytera Therapeutics, Inc.] Press Release Knopp Biosciences LLC announced the start of Phase II dose-ranging clinical trial in moderate-to-severe eosinophilic asthma. [Knopp Biosciences LLC] Press Release Hutchison China MediTech Limited has initiated a Phase I study of HMPL-523, its novel spleen tyrosine kinase inhibitor, in patients with ITP, an autoimmune disorder that can lead to increased risk of bleeding. [Hutchison China MediTech Limited] Press Release Genmab Announces Approval of DARZALEX® (Daratumumab) in Frontline Multiple Myeloma in Japan Genmab A/S announced that the Ministry of Health, Labor and Welfare in Japan has approved the use of DARZALEX in combination with bortezomib, melphalan and prednisone for the treatment of patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplant. [Genmab A/S] Press Release | |
| |
POLICY NEWS‘Paralysed by Anxiety’: Researchers Speak about Life in Troubled Ancient-DNA Lab The University of Adelaide has suspended the leader and founder of its premier ancient-DNA centre, Alan Cooper, following an investigation into the ‘culture’ at the Australian centre. The university has not given a reason for its decision, but current and former co-workers of Cooper – an award-winning evolutionary biologist who specializes in human migration – have told Nature that he bullied them or that they watched him bully others. [Nature] Editorial More Than 700 German Research Institutions Strike Open-Access Deal with Springer Nature A consortium of more than 700 German research institutions and libraries announced an agreement with publisher Springer Nature to make it simpler for authors to publish their papers open access. The agreement is the largest national open-access deal to date, but it doesn’t allow authors to publish open access in Nature or its sister journals. [ScienceInsider] Editorial As Brexit Nears, Britain’s Drugs, Devices and Pricing Regulators Seek the Exit Firm details on exactly how the UK will regulate new medicines is still to be decided after it leaves the EU later this year (caveats on timing abound), but we now know that the regulator won’t be run by Dr. Ian Hudson, who is stepping down after six years in charge. [FierceBiotech] Editorial
| |
EVENTSNEW Cell Death in Immunity and Inflammation Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESNEW Research Technologist (STEMCELL Technologies Inc.) NEW Assistant Professor and Postdoctoral Fellows – Immunology (Chinese Academy of Sciences) Scientific Communications Coordinator (STEMCELL Technologies Inc.) Research Associate – Human Immunology (STEMCELL Technologies Inc.) Scientist – Human Immunology (STEMCELL Technologies Inc.) Research Associate – Immune Cell Culture (STEMCELL Technologies Inc.) Laboratory Manager – Human Immunology (Karolinska Institutet) Postdoctoral Position – Cell Death, Inflammation and Immunity (University Hospital of Cologne) Professorship – Innate Immunity and Cardiovascular Repair (Goethe University Frankfurt am Main) Staff Scientist – Lead Immunotherapy Bioinformatician (Fred Hutchinson Cancer Research Center) Assistant Professor – Neuro-Immune/Neuro-Pharmacological Interactions (University of Pennsylvania) Postdoctoral Fellow – Quantitative Microscopy of Immune Cells (National Institute on Aging) Postdoctoral Position – Immunology of Enteric Infections (University of Utah) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Immune Regulation News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|